Ernexa Therapeutics Inc. (ERNA) quarterly income statement — complete revenue, gross profit & net income history
| Metric | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 | Q2'21 |
|---|
| Sales/Revenue | 0 | 0 | 0 | 0 | 0 | 1K | 487K | 47K | 47K | 17K | 51K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Revenue Growth % | - | -100% | -100% | -100% | -100% | -94.12% | 854.9% | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Cost of Goods Sold | 86K | 0 | 0 | 0 | 0 | 0 | -60K | 95K | 602K | 66K | 120K | 0 | 50K | 0 | 0 | 0 | 0 | 123K | 0 | 0 |
| COGS % of Revenue | - | - | - | - | - | - | -12.32% | 202.13% | 1280.85% | 388.24% | 235.29% | - | - | - | - | - | - | - | - | - |
| Gross Profit | -86K | 0 | 0 | 0 | 0 | 1K | 547K | -48K | -555K | -49K | -69K | 0 | -50K | 0 | 0 | 0 | 0 | -123K | 0 | 0 |
| Gross Margin % | - | - | - | - | - | 100% | 112.32% | -102.13% | -1180.85% | -288.24% | -135.29% | - | - | - | - | - | - | - | - | - |
| Gross Profit Growth % | - | -100% | -100% | 100% | 100% | 102.04% | 892.75% | - | -1010% | - | - | - | - | 100% | - | - | - | - | - | - |
| Operating Expenses | 3.46M | 2.09M | 1.99M | 2.5M | 2.73M | 2.7M | 2.81M | 4.88M | 5.23M | 5.72M | 5.44M | 4.55M | 5.27M | 4.74M | 8.3M | 13.88M | 6.3M | 8.41M | 86.28M | 10.01M |
| OpEx % of Revenue | - | - | - | - | - | 269800% | 576.18% | 10389.36% | 11131.91% | 33623.53% | 10658.82% | - | - | - | - | - | - | - | - | - |
| Selling, General & Admin | 1.63M | 1.42M | 958K | 1.36M | 1.42M | 1.54M | 3.38M | 3.9M | 3.77M | 4.51M | 3.98M | 2.59M | 3.59M | 3.7M | 3.34M | 5.43M | 4.51M | 4.16M | 4.23M | 4.58M |
| SG&A % of Revenue | - | - | - | - | - | 154000% | 694.25% | 8289.36% | 8029.79% | 26505.88% | 7801.96% | - | - | - | - | - | - | - | - | - |
| Research & Development | 1.92M | 676K | 1.03M | 1.14M | 1.31M | 1.16M | 1M | 987K | 1.46M | 1.21M | 1.46M | 1.5M | 1.67M | 1.96M | 4.96M | 1.69M | 1.78M | 4.25M | 1.49M | 5.43M |
| R&D % of Revenue | - | - | - | - | - | 115800% | 205.54% | 2100% | 3102.13% | 7117.65% | 2856.86% | - | - | - | - | - | - | - | - | - |
| Other Operating Expenses | -86K | 0 | 0 | 0 | 0 | 0 | -1000K | 0 | 0 | 0 | 0 | 460K | 0 | -921K | 0 | 1000K | 0 | 0 | 1000K | 0 |
| Operating Income | -3.55M | -2.09M | -1.99M | -2.5M | -2.73M | -2.7M | -2.26M | -4.93M | -5.79M | -5.76M | -5.5M | -4.55M | -5.32M | -4.74M | -8.3M | -13.88M | -6.3M | -8.54M | -86.28M | -10.01M |
| Operating Margin % | - | - | - | - | - | -269700% | -463.86% | -10491.49% | -12312.77% | -33911.76% | -10794.12% | - | - | - | - | - | - | - | - | - |
| Operating Income Growth % | -29.89% | 22.36% | 11.78% | 49.28% | 52.83% | 53.22% | 58.96% | -8.4% | -8.86% | -21.7% | 33.71% | 67.23% | 15.57% | 44.5% | 90.38% | -38.62% | 29.43% | -286.78% | - | - |
| EBITDA | -3.46M | -2.02M | -1.98M | -2.45M | -2.66M | -2.63M | -1.81M | -4.35M | -5.25M | -5.28M | -4.99M | -4.49M | -5.25M | -4.65M | -8.18M | -13.73M | -6.16M | -8.41M | -86.15M | -9.9M |
| EBITDA Margin % | - | - | - | - | - | -262900% | -371.25% | -9261.7% | -11161.7% | -31082.35% | -9780.39% | - | - | - | - | - | - | - | - | - |
| EBITDA Growth % | -30.03% | 22.97% | -9.29% | 43.81% | 49.28% | 50.25% | 63.75% | 2.96% | 0.15% | -13.61% | 39.04% | 67.32% | 14.68% | 44.71% | 90.5% | -38.72% | 30.23% | -285.57% | - | - |
| D&A (Non-Cash Add-back) | 86K | 69K | 17K | 55K | 69K | 68K | 451K | 578K | 541K | 481K | 517K | 63K | 62K | 86K | 121K | 152K | 138K | 123.4K | 124K | 117K |
| EBIT | -3.55M | -6.88M | -1.2M | -2.5M | -2.73M | -2.27M | -24.91M | -4.73M | -5.86M | -5.63M | -5.49M | -4.09M | -5.32M | -4.44M | -7.3M | -3.38M | -9.37M | -7.87M | -85.97M | -10.06M |
| Net Interest Income | 44K | 47K | -31K | 0 | 5K | -3.23M | -1.69M | -797K | -786K | -388K | -114K | 24K | 2K | -6K | -10K | -13K | -1K | -18.03K | -20K | -22K |
| Interest Income | 44K | 47K | 0 | 0 | 5K | 249K | 0 | 0 | 0 | 0 | 0 | 24K | 2K | 0 | 0 | 0 | 0 | 0 | - | 0 |
| Interest Expense | 0 | 0 | 31K | 0 | - | 3.48M | 1.69M | 797K | 786K | 388K | 114K | 0 | - | 6K | 10K | 13K | 1K | 18.03K | 20K | 22K |
| Other Income/Expense | -2M | 530K | 759K | -635K | -5.46M | -3.05M | -24.33M | -595K | -856K | -392K | -94K | 45K | -95K | 290K | 993K | 10.48M | -3.08M | 647K | 290K | -72K |
| Pretax Income | -5.55M | -1.56M | -1.23M | -3.14M | -8.19M | -5.75M | -26.59M | -5.53M | -6.64M | -6.16M | -5.6M | -4.5M | -5.41M | -4.45M | -7.31M | -3.4M | -9.38M | -7.89M | -85.99M | -10.09M |
| Pretax Margin % | - | - | - | - | - | -574800% | -5460.37% | -11757.45% | -14134.04% | -36217.65% | -10978.43% | - | - | - | - | - | - | - | - | - |
| Income Tax | -40K | -62K | 6K | 3K | 8K | 11K | 12K | 3K | 4K | -4K | -8K | 4K | 5K | 40K | 5K | 0 | 0 | 64K | 0 | 0 |
| Effective Tax Rate % | 0.72% | 3.96% | -0.49% | -0.1% | -0.1% | -0.19% | -0.05% | -0.05% | -0.06% | 0.06% | 0.14% | -0.09% | -0.09% | -0.9% | -0.07% | 0% | 0% | -0.81% | 0% | 0% |
| Net Income | -5.51M | -1.5M | -1.24M | -3.14M | -8.2M | -5.76M | -26.6M | -5.53M | -6.65M | -6.15M | -5.59M | -4.51M | -5.42M | -4.49M | -7.32M | -3.4M | -9.38M | -7.95M | -85.99M | -10.09M |
| Net Margin % | - | - | - | - | - | -575900% | -5462.83% | -11763.83% | -14142.55% | -36194.12% | -10962.75% | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 32.87% | 73.92% | 95.34% | 43.23% | -23.39% | 6.4% | -375.84% | -22.65% | -22.73% | -37.13% | 23.58% | -32.67% | 42.23% | 43.57% | 91.49% | 66.31% | 49.38% | -258.49% | - | - |
| Net Income (Continuing) | -5.51M | -1.5M | -1.24M | -3.14M | -8.2M | -5.76M | -26.6M | -5.53M | -6.65M | -6.15M | -5.59M | -4.51M | -5.42M | -4.49M | -7.32M | -3.4M | -9.38M | -7.95M | -85.99M | -10.09M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| EPS (Diluted) | -6.95 | -4.75 | -3.75 | -15.25 | -3.75 | -10.50 | -123.00 | -25.50 | -30.75 | -28.50 | -25.75 | -21.25 | -26.50 | -25.50 | -62.25 | 60.25 | -116.00 | -81.25 | -851.25 | -118.75 |
| EPS Growth % | -85.33% | 54.76% | 96.95% | 40.2% | 87.8% | 63.16% | -377.67% | -20% | -16.04% | -11.76% | 58.63% | -135.27% | 77.16% | 68.62% | 92.69% | 150.74% | 63.58% | -103.13% | - | - |
| EPS (Basic) | -6.95 | -4.75 | -3.75 | -15.25 | -3.75 | -10.50 | -123.00 | -25.50 | -30.75 | -28.50 | -25.75 | -21.25 | -26.50 | -25.50 | -62.25 | 60.25 | -116.25 | -81.25 | -851.25 | -118.75 |
| Diluted Shares Outstanding | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.61K | 107.25K | 104.08K | 101.08K | 84.9K |
| Basic Shares Outstanding | 792K | 314.16K | 329.04K | 207.16K | 2.13M | 2.06M | 216.4K | 216.4K | 216.4K | 216.4K | 216.4K | 212.12K | 205.08K | 176.06K | 117.64K | 117.6K | 107.24K | 104.08K | 101.08K | 84.9K |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |